• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

    2.292 +0.072 (+3.24%)
    Streaming Delayed Price Updated: 10:27 AM EST, Jan 16, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,445,450
    Open 2.240
    Bid (Size) 2.290 (6,500)
    Ask (Size) 2.300 (6,700)
    Prev. Close 2.220
    Today's Range 2.225 - 2.320
    52wk Range 1.639 - 6.500
    Shares Outstanding 305,252,194
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
    As the final bells ring on Wall Street for 2025, the biotechnology sector is celebrating a dramatic reversal of fortune. After years of navigating high interest rates and regulatory uncertainty, the... 
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    The Great Consolidation: Why 2026 is Set to Become the Year of the Mega-Deal
    As 2025 draws to a close, the global financial landscape is bracing for what analysts are calling an "Innovation Supercycle" in the mergers and acquisitions (M&A) market. With interest rates finally... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property

    Performance

    YTD
    -9.0%
    -9.0%
    1 Month
    +1.9%
    +1.9%
    3 Month
    +2.3%
    +2.3%
    6 Month
    -2.1%
    -2.1%
    1 Year
    -61.2%
    -61.2%

    More News

    Read More
    Why Are IOVA Shares Rising Today? ↗
    Via Stocktwits
    News headline image
    Earnings Scheduled For November 6, 2025 ↗
    Via Benzinga
    News headline image
    2 Beaten-Down Stocks That Will Soar in 2026, According to Wall Street ↗
    Via The Motley Fool
    Topics Death
    News headline image
    Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    2 Stocks That Could Soar by 52% and 282%, According to Wall Street ↗
    Via The Motley Fool
    News headline image
    Iovance (IOVA) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    Biotech Valuations Rise as New Clinical Platforms Show Progress
    Via Investor Brand Network
    News headline image
    Biotech Valuations Rise as New Clinical Platforms Show Progress
    From BioMedWire
    Via GlobeNewswire
    News headline image
    Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Down 75% in 12 Months, Can Iovance Biotherapeutics Stock Turn Things Around? ↗
    Via The Motley Fool
    News headline image
    2 Small-Cap Stocks With Far More Upside Than Any "Magnificent Seven" Stock, According to Wall Street ↗
    Via The Motley Fool
    News headline image
    Top movers in Thursday's session ↗
    Via Chartmill
    News headline image
    Synergy CHC (NASDAQ: SNYR) Expands FOCUSfactor® Beverage Rollout – Eyes $100M+ in 2026
    Via AB Newswire
    News headline image
    Top stock movements in today's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Via Benzinga
    News headline image
    Gapping stocks in Thursday's session ↗
    Via Chartmill
    News headline image
    Iovance Biotherapeutics Highlights Business Achievements, Pipeline Milestones, and Third Quarter 2025 Results
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Examining the Future: Iovance Biotherapeutics's Earnings Outlook ↗
    Via Benzinga
    News headline image
    Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
    Via Investor Brand Network
    News headline image
    Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
    Via FinancialNewsMedia
    News headline image
    IOVANCE INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Long-Term Iovance, Inc. Stockholders
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Iovance Biotherapeutics to Host Third Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, November 6, 2025
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Iovance Biotherapeutics, Inc. - Common Stock publicly traded?
    Yes, Iovance Biotherapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Iovance Biotherapeutics, Inc. - Common Stock trade on?
    Iovance Biotherapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Iovance Biotherapeutics, Inc. - Common Stock?
    The ticker symbol for Iovance Biotherapeutics, Inc. - Common Stock is IOVA on the Nasdaq Stock Market
    What is the current price of Iovance Biotherapeutics, Inc. - Common Stock?
    The current price of Iovance Biotherapeutics, Inc. - Common Stock is 2.292
    When was Iovance Biotherapeutics, Inc. - Common Stock last traded?
    The last trade of Iovance Biotherapeutics, Inc. - Common Stock was at 01/16/26 10:27 AM ET
    What is the market capitalization of Iovance Biotherapeutics, Inc. - Common Stock?
    The market capitalization of Iovance Biotherapeutics, Inc. - Common Stock is 699.64M
    How many shares of Iovance Biotherapeutics, Inc. - Common Stock are outstanding?
    Iovance Biotherapeutics, Inc. - Common Stock has 700M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.